Differences in hyperpolarized 3He ventilation imaging after 4 years in adults with cystic fibrosis

Journal of Magnetic Resonance Imaging

Volumn 41, Issue 6, 2015, Pages 1701-1707

  Paulin, Gregory A ^a,b   Svenningsen, Sarah ^a,b   Jobse, Brian N ^a   Mohan, Sindu ^b   Kirby, Miranda ^a,b   Lewis, James F ^b   Parraga, Grace ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

3He; cystic fibrosis; hyperpolarized gas; lung disease; magnetic resonance imaging

Indexed keywords

HELIUM; ISOTOPE;

ADULT; ARTICLE; BRONCHODILATATION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; HOSPITALIZATION; HUMAN; INFORMED CONSENT; INSPIRATORY CAPACITY; LUNG CYSTIC FIBROSIS; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PLETHYSMOGRAPH; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; TOTAL LUNG CAPACITY; VENTILATION DEFECT PERCENT; PATHOPHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; CYSTIC FIBROSIS; FEMALE; HELIUM; HOSPITALIZATION; HUMANS; ISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; RESPIRATORY FUNCTION TESTS;

EID: 84930037843     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24744     Document Type: Article

References (22)

1. O'Sullivan BP, Freedman SD,. Cystic fibrosis. Lancet 2009; 373: 1891-1904.
2. Corey M, Farewell V,. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996; 143: 1007-1017.
3. Que C, Cullinan P, Geddes D,. Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax 2006; 61: 155-157.
4. Taylor-Robinson D, Whitehead M, Diderichsen F, et al., Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 2012; 67: 860-866.
5. Corey M, McLaughlin FJ, Williams M, Levison H,. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 583-591.
6. Sanders DB, Li Z, Brody AS, Farrell PM,. Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med 2011; 184: 816-821.
7. Brody AS, Sucharew H, Campbell JD, et al., Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 2005; 172: 1128-1132.
8. Amin R, Charron M, Grinblat L, et al., Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. Radiology 2012; 264: 868-875.
9. Kirby M, Svenningsen S, Ahmed H, et al., Quantitative evaluation of hyperpolarized helium-3 magnetic resonance imaging of lung function variability in cystic fibrosis. Acad Radiol 2011; 18: 1006-1013.
10. Donnelly LF, MacFall JR, McAdams HP, et al., Cystic fibrosis: combined hyperpolarized 3He-enhanced and conventional proton MR imaging in the lung-preliminary observations. Radiology 1999; 212: 885-889.
11. Loeve M, Krestin GP, Rosenfeld M, de Bruijne M, Stick SM, Tiddens HA,. Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 2013; 42: 844-857.
12. Schauer DA, Linton OW,. National Council on Radiation Protection and Measurements report shows substantial medical exposure increase. Radiology 2009; 253: 293-296.
13. Bannier E, Cieslar K, Mosbah K, et al., Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function. Radiology 2010; 255: 225-232.
14. Puderbach M, Eichinger M, Haeselbarth J, et al., Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray. Invest Radiol 2007; 42: 715-725.
15. Eichinger M, Optazaite DE, Kopp-Schneider A, et al., Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol 2012; 81: 1321-1329.
16. Horn FC, Deppe MH, Marshall H, Parra-Robles J, Wild JM,. Quantification of regional fractional ventilation in human subjects by measurement of hyperpolarized 3He washout with 2D and 3D MRI. J Appl Physiol 2014; 116: 129-139.
17. Wielputz MO, Puderbach M, Kopp-Schneider A, et al., Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2014; 189: 956-965.
18. Mentore K, Froh DK, de Lange EE, Brookeman JR, Paget-Brown AO, Altes TA,. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005; 12: 1423-1429.
19. Miller MR, Hankinson J, Brusasco V, et al., Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
20. Parraga G, Ouriadov A, Evans A, et al., Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007; 42: 384-391.
21. Kirby M, Heydarian M, Svenningsen S, et al., Hyperpolarized 3He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012; 19: 141-152.
22. Sheikh K, Paulin GA, Svenningsen S, et al., Pulmonary ventilation defects in older never-smokers. J Appl Physiol 2014; 117: 297-306.